Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
colorectal cancer
Fierce Pharma
Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO
With phase 3 results for a potential new blockbuster on the horizon and a growing pipeline, Exelixis' CEO laid out his aspirations for the company.
Angus Liu
Jan 16, 2026 1:00pm
GSK inks model deal in $50M bet on Noetik's cancer AI platform
Jan 8, 2026 10:30am
Pfizer maps out $865M Cartography discovery deal
Jan 6, 2026 7:30am
Leap jumps from bio to crypto after winding down cancer program
Nov 12, 2025 10:44am
Lyell signs deal for phase 1-stage colorectal cancer CAR-T
Nov 10, 2025 9:45am
Inhibrx intends FDA submission after phase 2 bone cancer win
Oct 24, 2025 6:40am
